BST-105

N/A

Report date: 2025/10/22 15:36:29
NME

Base Information

Drug NameBST-105
Drug Alias NameBST-105
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiosight Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosight Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A